{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:55:19Z","timestamp":1790081719561,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neuropharm.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T02:19:03Z","timestamp":1424744343000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Peripheral \u03bc-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals"],"prefix":"10.1016","volume":"93","author":[{"given":"Landon D.","family":"Baillie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Schmidhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.02.011_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2010.06.028","article-title":"Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK\/BK(Ca)) channel opening","volume":"151","author":"Akerman","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.brainresbull.2007.07.008","article-title":"DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens","volume":"74","author":"Al-Khrasani","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2012.04.016","article-title":"Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres","volume":"63","author":"Baillie","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jneumeth.2011.04.015","article-title":"Functional imaging within individual pain fibres ex\u00a0vivo with optical microscopy","volume":"198","author":"Baillie","year":"2011","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1152\/physrev.00049.2009","article-title":"Ca2+-activated K+ channels: from protein complexes to function","volume":"90","author":"Berkefeld","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.105.096032","volume":"317","author":"Bileviciute-Ljungar","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/74438","article-title":"New paths to pain relief","volume":"18","author":"Brower","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1471-4159.2009.06138.x","article-title":"Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain","volume":"110","author":"Chen","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib11","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2008.09.001","article-title":"Control of K(Ca) channels by calcium nano\/microdomains","volume":"59","author":"Fakler","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresprot.2005.10.003","article-title":"Eye-wiping test: a sensitive animal model for acute trigeminal pain studies","volume":"16","author":"Farazifard","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/jpet.104.075176","article-title":"Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat","volume":"312","author":"Furst","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2235","article-title":"Nociceptor sensitization in pain pathogenesis","volume":"16","author":"Gold","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2013.00132","article-title":"Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions","volume":"4","author":"Iwaszkiewicz","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib17","series-title":"Neurogenic Inflammation in Health and Disease","author":"Jancs\u00f3","year":"2009"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pain.2013.12.005","article-title":"BKCa channels expressed in sensory neurons modulate inflammatory pain in mice","volume":"155","author":"Lu","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuron.2013.01.030","article-title":"Peptidergic CGRPalpha primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold","volume":"78","author":"McCoy","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib20","series-title":"Wall and Melzack's Texbook of Pain","first-page":"3","article-title":"Peripheral mechanisms of cutaneous nociception","author":"Meyer","year":"2005"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"Muller","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.102.032797","article-title":"Cellular mechanisms of neurogenic inflammation","volume":"302","author":"Richardson","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0166-2236(96)80026-9","article-title":"Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation","volume":"19","author":"Sah","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1602\/neurorx.2.4.662","article-title":"Targeting chronic and neuropathic pain: the N-type calcium channel comes of age","volume":"2","author":"Snutch","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2003.10.049","article-title":"In\u00a0vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphone","volume":"483","author":"Spetea","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199506223322506","article-title":"The control of pain in peripheral tissue by opioids","volume":"332","author":"Stein","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2013.00123","article-title":"Targeting pain and inflammation by peripherally acting opioids","volume":"4","author":"Stein","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1124\/pr.110.003145","article-title":"Modulation of peripheral sensory neurons by the immune system: implications for pain therapy","volume":"63","author":"Stein","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm908","article-title":"Attacking pain at its source: new perspectives on opioids","volume":"9","author":"Stein","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cne.20106","article-title":"Axon diameters and intradural trajectories of the dural innervation in the rat","volume":"473","author":"Strassman","year":"2004","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tins.2013.12.002","article-title":"Opening paths to novel analgesics: the role of potassium channels in chronic pain","volume":"37","author":"Tsantoulas","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.011_bib34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuroscience.2003.08.035","article-title":"Modulation of action potential firing by iberiotoxin and NS1619 in rat dorsal root ganglion neurons","volume":"122","author":"Zhang","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.011_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0928-4257(93)90021-K","article-title":"Calcium and transmitter release","volume":"87","author":"Zucker","year":"1993","journal-title":"J.\u00a0Physiol. Paris"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T18:51:11Z","timestamp":1537815071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":35,"alternative-id":["S0028390815000581"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral \u03bc-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}